ADDITIONAL METHADONE INCREASES CRAVING FOR HEROIN: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CHRONIC OPIATE USERS RECEIVING METHADONE SUBSTITUTION TREATMENT
Saved in:
CURRAN, H.V., ET AL., ADDITIONAL METHADONE INCREASES CRAVING FOR HEROIN: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CHRONIC OPIATE USERS RECEIVING METHADONE SUBSTITUTION TREATMENT. ADDICTION, Vol. 94, no. 5 (1999), p. 665-674.
Ref.
77080
Location:
SIIS R.696
Palabras clave:
Ceguera, Drogodependencias, Efectos no deseados, Evaluación de servicios, Metadona, Opiáceos, Programas de bajo umbral, Programas de mantenimiento, Síndrome de abstinencia, Tratamiento médico
Ceguera, Drogodependencias, Efectos no deseados, Evaluación de servicios, Metadona, Opiáceos, Programas de bajo umbral, Programas de mantenimiento, Síndrome de abstinencia, Tratamiento médico
Similar Items: ADDITIONAL METHADONE INCREASES CRAVING FOR HEROIN: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CHRONIC OPIATE USERS RECEIVING METHADONE SUBSTITUTION TREATMENT
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SAFETY STUDY OF HIGHDOSE DEXTROMETHORPAN IN METHADONE-MAINTAINED MALE INPATIENTS
- TREATMENT OF METHADONE MAINTAINED PATIENTS WITH ADULT ADHD: DOUBLE BLIND COMPARISON OF METHYLPHENIDADE, BUPROPION AND PLACEBO
- RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL OF MODAFINIL FOR THE TREATMENT OF METHAMPHETAMINE DEPENDECE
- A META-ANALYSIS OF DOUBLE-BLIND PLACEBO-CONTROLLED TRIALS OF CLONIDINE FOR SMOKING CESSATION
- DOUBLE-BLIND RANDOMIZED TRIAL OF BUPRENORPHINE AND METHADONE IN OPIATE DEPENDENCE
- EFFICACY OF A NICOTINE INHALER IN SMOKING CESSATION: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL